tiprankstipranks
MetaVia (MTVA)
NASDAQ:MTVA
US Market
MTVA
MetaVia
RESEARCH TOOLSreports

MetaVia (MTVA) Stock News & Sentiment

464 Followers
MetaVia Advances DA-1726 Obesity Trial With First Patient
Premium
Company Announcements
MetaVia Advances DA-1726 Obesity Trial With First Patient
3d ago
8K
MTVA
MetaVia (MTVA): Differentiated Dual-Agonist Obesity Therapy and Solid Cash Runway Underpin Buy Rating
Premium
Ratings
MetaVia (MTVA): Differentiated Dual-Agonist Obesity Therapy and Solid Cash Runway Underpin Buy Rating
12d ago
MTVA
Maintaining Buy on MetaVia: Advancing DA-1726 Clinical Profile and Differentiated Obesity/MASH Strategy Despite Reduced Target Price
Premium
Ratings
Maintaining Buy on MetaVia: Advancing DA-1726 Clinical Profile and Differentiated Obesity/MASH Strategy Despite Reduced Target Price
17d ago
MTVA
MetaVia Updates Investor Strategy for Obesity and MASH
Premium
Company Announcements
MetaVia Updates Investor Strategy for Obesity and MASH
18d ago
8K
MTVA
Metavia Inc. (MTVA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Metavia Inc. (MTVA) Q4 Earnings Cheat Sheet
21d ago
MTVA
MetaVia Advances DA-1726 Obesity Drug into Phase 1 Part 3
Premium
Company Announcements
MetaVia Advances DA-1726 Obesity Drug into Phase 1 Part 3
26d ago
8K
MTVA
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
1M ago
IPI
MSS
More MTVA News >

MTVA News on the Web

MetaVia Advances DA-1726 Obesity Trial With First Patient
TipRanks News
Neutral
MetaVia says first patient dosed in Part 3 of Phase 1 trial of DA-1726
TipRanks News
Bullish
MetaVia (MTVA): Differentiated Dual-Agonist Obesity Therapy and Solid Cash Runway Underpin Buy Rating
TipRanks News
Bullish
Maintaining Buy on MetaVia: Advancing DA-1726 Clinical Profile and Differentiated Obesity/MASH Strategy Despite Reduced Target Price
TipRanks News
Bullish
MetaVia Updates Investor Strategy for Obesity and MASH
TipRanks News
Neutral
MetaVia: Cash position adequate to fund operations into 4Q26
TipRanks News
Neutral
MetaVia CEO says ‘significant progress advancing our cardiometabolic portfolio’
TipRanks News
Bullish
Metavia Inc. (MTVA) Q4 Earnings Cheat Sheet
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
MTVA
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MTVA’s Media Buzz Sentiment?
2 articles about MTVA were published this week. In an average week, 2.5 articles are published.
    What is MTVA’s weekly average amount of articles?
    In an average week, 2.5 articles about MTVA are published.
      What is MTVA’s News Sentiment?
      100% of articles about MTVA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        TXTMProText Mobility
        STAAStaar Surgical
        IVVDInvivyd
        ALLOAllogene Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week